Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
229.00    1.00 (0.44%)
Bid:
228.50
Ask:
230.00
Spread: 1.50 (0.656%)
Market Cap: £632.99m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Director/PDMR Shareholding

3 Mar 2014 16:15

RNS Number : 3970B
Morgan Advanced Materials PLC
03 March 2014
 



Notification of interests of directors/persons discharging managerial responsibility and connected persons ("PDMRs")

3 March 2014

This notification is made pursuant to DTR 3.1.4R(1)(a).

The Company announces that on 28 February 2014 awards over ordinary 25p shares in the Company were made to the Directors and PDMRs listed below under the Company's Long-Term Incentive Plan 2004 (LTIP), including the HMRC approved Schedule.

The awards under the LTIP comprise up to three elements, (i) and (iii) relate to certain UK participants: (i) an HM Revenue & Customs approved option over shares up to the value of £30,000 with an exercise price of 338.34 pence per share; (ii) an LTIP award in the form of a conditional award of free shares to the value of the remainder of the award; and (iii) a funding award, also in the form of a conditional award of free shares, over such number of shares whose value at exercise of the approved option equals the value of the approved option on award.

Subject to satisfaction of performance targets, awards under the LTIP will vest in three years' time.

In addition to the satisfaction of the performance targets, the approved option will only vest in the event that the market value of a share at vesting is greater than 338.34 pence per share. The funding award is used to fund the exercise price of the approved option and will be satisfied by shares from the Company's employee benefit trust.

Name

Number of shares subject to award (LTIP award and approved option, where applicable)

 

Maximum number of shares subject to funding award (not retained by participant)

Mark Robertshaw (Director)

166,697 LTIP

8,866 Approved Option

8,866

Kevin Dangerfield (Director)

81,436 LTIP

7,232 Approved Option

7,232

Andrew Hosty (Director)

93,101

0

Peter Blausten (PDMR)

20,690 LTIP

8,866 Approved Option

8,866

Paul Boulton (PDMR)

29,556

0

Ralph Gomarsall (PDMR)

8,866

0

Bill Grab (PDMR)

22,167

0

Simon Halliday (PDMR)

29,556

0

Andrew Riley (PDMR)

29,556

0

Ian Robb (PDMR)

36,945

0

John Stang (PDMR)

36,945

0

 

Following the grant of awards detailed above, the total number of shares in respect of which awards are held by those individuals pursuant to the Company's LTIP are detailed below:

Name

Total number of shares held pursuant to LTIP awards

Mark Robertshaw

482,476

Kevin Dangerfield

270,897

Andrew Hosty

292,914

Peter Blausten

93,495

Paul Boulton

93,495

Ralph Gomarsall

28,047

Bill Grab

48,515

Simon Halliday

87,102

Andrew Riley

93,495

Ian Robb

95,263

John Stang

81,210

 

 

Enquiries: Stephanie Mackie, Morgan Advanced Materials plc

 

Tel: 01753 837000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLRVVIVIIS
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.